Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma

Jessica E. Sagers(Massachusetts Eye and Ear Infirmary), Konstantina M. Stanković(Massachusetts Eye and Ear Infirmary)
Scientific Reports
March 6, 2020
Cited by 36


Related Papers